Australian startup develops nasal spray technology for mental health disorders
Therapeutics | News | 0 Comment | 30 Jul, 2021
A nasal spray technology that enables the delivery of psychedelic and non-psychedelic drugs to treat mental health disor...Read more
Australia advocates cognitive behavioural therapy for perinatal care
Therapeutics | News | 0 Comment | 29 Jul, 2021
New research from Monash University has found that a non-drug sleep program, using Cognitive Behavioural Therapy (CBT), ...Read more
China develops novel 'bacterial gene markers' test for early detection of colon cancer
Therapeutics | News | 0 Comment | 29 Jul, 2021
The faecal immunochemical test (FIT) is commonly used to screen for colorectal cancer but it has low sensitivity (around...Read more
‘Hard-to-drug targets have become our prime focus’
Therapeutics | Opinion | By Hithaishi C Bhaksar | 2 Comment | 29 Jul, 2021
Hummingbird Bioscience, an innovative clinical-stage biotech company with its APAC headquarter in Singapore, is focused ...Read more
Gilead Sciences launches Asia Pacific ALL4LIVER Grant 2021 with focus on hepatitis B
Therapeutics | News | 0 Comment | 28 Jul, 2021
American biopharma firm Gilead Sciences, Inc. has announced the launch of the 2021 Gilead Asia Pacific ALL4LIVER Grant, ...Read more
Industry-academia partnership in South Korea for non-alcoholic steatohepatitis treatment
Therapeutics | News | 0 Comment | 28 Jul, 2021
Deargen, an artificial intelligence (AI)-powered drug discovery and development startup, has signed an agreement with So...Read more
Singapore, US assess risk of vascular inflammation for diabetes patients
Therapeutics | News | 0 Comment | 28 Jul, 2021
A team of international scientists from Nanyang Technological University, Singapore (NTU Singapore), Tan Tock Seng Hospi...Read more
Japan uses quantum physics to destroy cancer cells
Therapeutics | News | 0 Comment | 27 Jul, 2021
Scientists at Japan-based Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) and colleague...Read more
China uncovers neurodegeneration mechanism of Alzheimer’s
Therapeutics | News | 0 Comment | 27 Jul, 2021
Alzheimer’s Disease (AD), the most common type of dementia, causes the death of neurons and leads to shrinking of ...Read more
Therapeutics | Opinion | 2 Comment | 23 Jul, 2021
In an email interaction with BioSpectrum, EpimAb’s Founder and CEO, Dr Chengbin Wu tells us more about the company...Read more
Australia examines use of hemp extracts to treat anxiety, seizures
Therapeutics | News | 0 Comment | 23 Jul, 2021
Pharmacologists at the University of Sydney in Australia have found tantalising clues as to why low-dose CBD products co...Read more
Korean firm Celltrion developing solution to treat COVID-19 patients at home
Therapeutics | News | 0 Comment | 23 Jul, 2021
Inhalon Biopharma, Inc., a US-based clinical-stage immunotherapy company developing an inhaled "muco-trapping" anti...Read more
Novigenix wins 2021 Felix Burda award in Medicine & Science
Therapeutics | News | 0 Comment | 22 Jul, 2021
Novigenix SA, a leading Swiss biotech that develops and commercializes Immuno-Transcriptomic precision oncology solution...Read more
NZ lays focus on combined screening of stomach and bowel cancer
Therapeutics | News | 0 Comment | 22 Jul, 2021
Dr Stephen Inns and his team from the University of Otago, in New Zealand (NZ) have secured almost $250,000 from the Hea...Read more
Quest for permanent correction of underlying genetic defect continues
Therapeutics | Opinion | By Ayesha Siddiqui | 2 Comment | 21 Jul, 2021
After years of research, the field of gene therapies is at a tipping point. Recent years have seen immense progress in t...Read more
Terumo Europe and UMCU ink MoU to develop solutions in interventional oncology
Therapeutics | News | 0 Comment | 21 Jul, 2021
Terumo Europe and University Medical Center Utrecht (UMC Utrecht) have announced that they signed a Memorandum of Unders...Read more
Taiwan links antihypertensive drug usage with lower risk of dementia
Therapeutics | News | 0 Comment | 20 Jul, 2021
According to a recent study done by researchers in Taiwan, angiotensin receptor blockers (ARBs) may have protective effe...Read more
Therapeutics | Opinion | By Devin Partida is a medical and health tech writer from San Francisco, California. She also writes about medical technologies, AI and cybersecurity on ReHack.com. | 0 Comment | 20 Jul, 2021
Millennials Have Elevated Risks for Some Obesity-Related Cancers The American Cancer Society led a study that l...Read more